DNA methylation of ARHGAP30 is negatively associated with ARHGAP30 expression in lung adenocarcinoma, which reduces tumor immunity and is detrimental to patient survival
Figure 7.KEGG pathway-based GSEA of ARHGAP30 in lung adenocarcinoma (LUAD). (A) Bar chart of KEGG pathway-based GSEA of ARHGAP30 in LUAD (FDR < 0.05). (B1–B16) GSEA enrichment analysis Plots of 16 tumor immune-related KEGG gene sets (FDR < 0.05).